Functional Effects of BoNT-A Application in Masseter Muscle in Patients with Symptoms of Bruxism
Toxins · 2025
DOI: 10.3390/toxins17110540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Krystian Matusz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Poznań University of Medical Sciences, 60-781 Poznań, Poland. Hauptthemen laut MEDLINE: Masseter Muscle, Botulinum Toxins, Type A, Bruxism, Neuromuscular Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bruxism, defined as a repetitive jaw-muscle activity characterized by clenching or grinding of teeth and/or by bracing or thrusting of the mandible, is a prevalent behavior affecting up to 22% of adults worldwide. While traditionally viewed as a disorder, current understanding recognizes bruxism as a behavior that may have both positive and negative consequences. Objective assessment methods for evaluating the effectiveness of interventions in symptomatic patients remain limited. This article presents the first longitudinal study using myotonometry to quantify changes in masseter muscle following botulinum toxin type A (BoNT-A) treatment in patients with symptoms of bruxism. In total, 57 patients were recruited and their masseter muscle tone, stiffness, elasticity, relaxation time, and creep parameters were measured. Measurements were performed at baseline, 3 weeks, and 3 months post-injection during both rest and maximum voluntary contraction. BoNT-A treatment produced significant improvements in all biomechanical parameters, with the greatest effects observed in patients with the highest baseline muscle values. The objective biomechanical changes correlated with the duration of BoNT-A’s therapeutic effects. These findings establish myotonometry as a valuable tool for objective assessment of masticatory muscle function and demonstrate that BoNT-A produces measurable, long-lasting biomechanical changes in masseter muscle parameters, supporting its possible clinical application in this challenging condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Poznań University of Medical Sciences, 60-781 Poznań, Poland.
- Department of Neurology, Municipal Hospital, 60-834 Poznań, Poland.
- Department of Orthodontics and Temporomandibular Disorders, Poznań University of Medical Sciences, 60-781 Poznań, Poland.
- Department of Computer Science and Statistics, Poznań University of Medical Sciences, 61-806 Poznań, Poland.
ORCID-Profile: Krystian Matusz, Artur Drużdż, Natalie Górna, Małgorzata Gałczyńska-Rusin, Agata Czajka-Jakubowska, Michał Michalak, Agnieszka Przystańska
Zitieren
APA
Matusz, K., Drużdż, A., Górna, N., Glapiński, M., Gałczyńska-Rusin, M., Czajka-Jakubowska, A., Michalak, M., & Przystańska, A. (2025). Functional Effects of BoNT-A Application in Masseter Muscle in Patients with Symptoms of Bruxism. Toxins. https://doi.org/10.3390/toxins17110540
Vancouver
Matusz K, Drużdż A, Górna N, Glapiński M, Gałczyńska-Rusin M, Czajka-Jakubowska A, et al. Functional Effects of BoNT-A Application in Masseter Muscle in Patients with Symptoms of Bruxism. Toxins. 2025. doi:10.3390/toxins17110540
BibTeX
@article{Matusz2025,
author = {Matusz, Krystian and Drużdż, Artur and Górna, Natalie and Glapiński, Mariusz and Gałczyńska-Rusin, Małgorzata and Czajka-Jakubowska, Agata and Michalak, Michał and Przystańska, Agnieszka},
title = {Functional Effects of BoNT-A Application in Masseter Muscle in Patients with Symptoms of Bruxism},
journal = {Toxins},
year = {2025},
doi = {10.3390/toxins17110540}
}
EUVIMED